Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics - Published by Business Communications Company Inc. in March 2010
INTRODUCTION
STUDY GOALS AND OBJECTIVES
BCC’s goal for this study was to examine the status of commercial epigenomics technologies and products and assess their worldwide growth potential over a 5-year period from 2009 to 2014. We analyzed the four important market ...(more)
International Directory of Biotechnology Companies 2010 Published by API Publishing in January 2010
The International Directory of Biotechnology Companies 2009 is one of the most comprehensive and accurate Directory of companies and executives in the biotechnology industry that have ever been published. It contains more than 3,000 biotechnology companies and 10,000 ex...(more)
Global Pharmaceutical Biotech Market 2010-2025 Published by Visiongain in December 2009
The global pharmaceutical biotech market continues to experience high growth, with developers ranging from major pharmaceutical companies to specialist pharmaceutical firms. Significant R&D efforts and innovative new treatments will lead to further expansion of the ...(more)
Global Pharmaceutical Biotech Market 2010-2025 Published by Visiongain in December 2009
The global pharmaceutical biotech market continues to experience high growth, with developers ranging from major pharmaceutical companies to specialist pharmaceutical firms. Significant R&D efforts and innovative new treatments will lead to further expansion of the ...(more)
The Growth of the Biologics Market and Role of Asia Pacific Published by Frost and Sullivan in November 2009
This research service aims to provide an overview of biologics, its use as therapy option, the growth of the biologics and biopharmaceutical industry and its relation to Asia, and recommendations on increasing the industry presence in Asia....(more)
Global Stem Cell and Advanced Technologies Market Published by marketsandmarkets in November 2009
Report DescriptionThe stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are exp...(more)
Biosimilars: Beyond the first product wave Published by Espicom in October 2009
With the prospect of high-profile, high-value biosimilar products on the horizon, the sector is poised to realise its full potential – but only if the US can establish a regulatory pathway. This report addresses key issues and provides insight into how the sector may de...(more)
European Biomarker Analysis Market Published by Frost and Sullivan in September 2009
This research service gives a detailed analysis of the biomarker analysis market in Europe from 2005-2015....(more)
Registered Office: 2a Altons House Office Park, Gatehouse Way, Aylesbury, HP19 3XU, UK
Registered in England and Wales No. 3240740 VAT No. GB 685 4343 10
CMSInfo (Chiltern Magazine Services Ltd.) is a company registered at Companies House in England and Wales (Company No. 3240740). CMSInfo is also registered in accordance with the Data Protection Act 1998 (registration number R0094104).
